Drug Trial Radar · NCT05399641
Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis
Last checked: Nov 20, 2026Latest source record: Jul 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
May 1, 2022
Primary completion
May 16, 2023
Study completion Aug 2, 2023
Sponsor
- Lead sponsor
- Scynexis, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 1, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will treat subjects with complicated VVC who have failed prior fluconazole therapy with Ibrexafungerp for 1, 3 or 7 days of treatment.
Conditions
- Vulvovaginal Candidiasis
Interventions
IbrexafungerpDrug
Each day dosing will consist of two 150mg tablets taken BID.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical CureTime frame: 14 days post-Baseline - Test-Of-Cure (TOC)
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Precision Trials, AZ
Phoenix, Arizona
Women's Healthcare Research
San Diego, California
Wake Research (MCCR)
San Diego, California
New Age Medical Research
Miami, Florida
Wake (Mount Vernon Clinical Research)
Atlanta, Georgia
Clinical Research Prime
Idaho Falls, Idaho
Leavitt Women's Healthcare
Idaho Falls, Idaho
Women Under Study
New Orleans, Louisiana
Massachusetts's General
Boston, Massachusetts
Wayne State University
Detroit, Michigan
Consultants in Women's Healthcare
St Louis, Missouri
Wake Research (CRCN)
Las Vegas, Nevada
Capital Health Lawrence OBGYN
Lawrenceville, New Jersey
Center for Colposcopy
Lake Success, New York
Wake Research (Carolina Institute for Clinical Research)
Fayetteville, North Carolina
UWCR - Raleigh
Raleigh, North Carolina
Lyndhurst Clinical Research
Winston-Salem, North Carolina
Cleveland Clinic
Cleveland, Ohio
Oregon Health and Science University
Portland, Oregon
Jefferson University
Philadelphia, Pennsylvania
Medical Research Center
Memphis, Tennessee
Discovery Clinical Trials
Dallas, Texas
TMC Life Research, Inc
Houston, Texas
Discovery Clinical Trials
McAllen, Texas
Seattle Clinical Research Center
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.